{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:23:15Z","timestamp":1777868595856,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,21]],"date-time":"2027-02-21T00:00:00Z","timestamp":1803168000000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA263575"],"award-info":[{"award-number":["R01CA263575"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA256973"],"award-info":[{"award-number":["R01CA256973"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01CA217798"],"award-info":[{"award-number":["P01CA217798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA206444"],"award-info":[{"award-number":["R01CA206444"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA273319"],"award-info":[{"award-number":["R01CA273319"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA228524"],"award-info":[{"award-number":["R01CA228524"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA210637"],"award-info":[{"award-number":["R01CA210637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA200466"],"award-info":[{"award-number":["U01CA200466"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA210240"],"award-info":[{"award-number":["U01CA210240"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["LB606\/2022-10"],"award-info":[{"award-number":["LB606\/2022-10"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA273349"],"award-info":[{"award-number":["R01CA273349"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.canlet.2026.218276","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:19:22Z","timestamp":1769213962000},"page":"218276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the DDX3\/PAF1 axis enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"644","author":[{"given":"Palanisamy","family":"Nallasamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parthasarathy","family":"Seshacharyulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchita","family":"Rauth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashu","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saravanakumar","family":"Marimuthu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh","family":"Varadharaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhulatha","family":"Bommideni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Mallya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahraa Wajih","family":"Alsafwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subodh M.","family":"Lele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-1423","authenticated-orcid":false,"given":"Venu","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9470-9317","authenticated-orcid":false,"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-193X","authenticated-orcid":false,"given":"Moorthy P.","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218276_bib1","first-page":"7","article-title":"Cancer statistics","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218276_bib2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218276_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.canlet.2026.218276_bib4","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218276_bib5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218276_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1158\/2159-8290.CD-21-1331","article-title":"Expanding the reach of precision oncology by drugging all KRAS mutants","volume":"12","author":"Hofmann","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218276_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2208470","article-title":"Sotorasib in KRAS p.G12C-Mutated advanced pancreatic cancer","volume":"388","author":"Strickler","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218276_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS mutation: from undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218276_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1033684","article-title":"The human DEAD-box helicase DDX3X as a regulator of mRNA translation","volume":"10","author":"Ryan","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218276_bib10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejcb.2018.08.001","article-title":"Investigating nucleo-cytoplasmic shuttling of the human DEAD-box helicase DDX3","volume":"97","author":"Brennan","year":"2018","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218276_bib11","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.1231499","article-title":"RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in wnt-beta-catenin signaling","volume":"339","author":"Cruciat","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218276_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-019-1551-2","article-title":"DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome","volume":"573","author":"Samir","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218276_bib13","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1128\/MCB.01603-12","article-title":"Human DEAD box helicase 3 couples IkappaB kinase epsilon to interferon regulatory factor 3 activation","volume":"33","author":"Gu","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218276_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tranon.2018.09.002","article-title":"Targeting DDX3 in medulloblastoma using the small molecule inhibitor RK-33","volume":"12","author":"Tantravedi","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218276_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PAI.0000000000000422","article-title":"Applying DDX3X biomarker to discriminate atypical from benign meningiomas in tissue microarray","volume":"26","author":"Tsai","year":"2018","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.canlet.2026.218276_bib16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.15252\/emmm.201404368","article-title":"Targeting DDX3 with a small molecule inhibitor for lung cancer therapy","volume":"7","author":"Bol","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.canlet.2026.218276_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-025-08080-3","article-title":"Targeting FAM134B-DDX3X axis inhibiting AKT signaling in hepatocellular carcinoma","volume":"16","author":"Mo","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218276_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063548","article-title":"Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer","volume":"8","author":"Bol","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218276_bib19","doi-asserted-by":"crossref","first-page":"28312","DOI":"10.18632\/oncotarget.4873","article-title":"Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer","volume":"6","author":"Heerma van Voss","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218276_bib20","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1158\/0008-5472.CAN-16-0440","article-title":"RK-33 radiosensitizes prostate cancer cells by blocking the RNA helicase DDX3","volume":"76","author":"Xie","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218276_bib21","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1038\/onc.2015.336","article-title":"RNA helicase DDX3: a novel therapeutic target in ewing sarcoma","volume":"35","author":"Wilky","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218276_bib22","doi-asserted-by":"crossref","first-page":"eadw9519","DOI":"10.1126\/sciadv.adw9519","article-title":"RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis","volume":"11","author":"Wang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218276_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1158\/0008-5472.CAN-17-2175","article-title":"PD2\/PAF1 at the crossroads of the cancer network","volume":"78","author":"Karmakar","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218276_bib24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/mc.23599","article-title":"CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1","volume":"62","author":"Zhang","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2026.218276_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11060-023-04506-0","article-title":"RFX2 promotes tumor cell stemness through epigenetic regulation of PAF1 in spinal ependymoma","volume":"165","author":"Zhang","year":"2023","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218276_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112979","article-title":"Aberrant accumulation of Kras-dependent pervasive transcripts during tumor progression renders cancer cells dependent on PAF1 expression","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218276_bib27","doi-asserted-by":"crossref","first-page":"14806","DOI":"10.18632\/oncotarget.14775","article-title":"hPaf1\/PD2 interacts with OCT3\/4 to promote self-renewal of ovarian cancer stem cells","volume":"8","author":"Karmakar","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218276_bib28","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1002\/stem.237","article-title":"RNA polymerase II associated factor 1\/PD2 maintains self-renewal by its interaction with Oct3\/4 in mouse embryonic stem cells","volume":"27","author":"Ponnusamy","year":"2009","journal-title":"Stem Cell."},{"key":"10.1016\/j.canlet.2026.218276_bib29","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2020.07.053","article-title":"RNA polymerase II-Associated factor 1 regulates stem cell features of pancreatic cancer cells, independently of the PAF1 complex, via interactions with PHF5A and DDX3","volume":"159","author":"Karmakar","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218276_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218065","article-title":"Inhibition of DDX3 modulates immune signaling in aggressive breast cancers","volume":"634","author":"Vesuna","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218276_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12032-017-0889-2","article-title":"Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer","volume":"34","author":"Heerma van Voss","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.canlet.2026.218276_bib32","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/s41467-019-13100-w","article-title":"Characterization of genetic subclonal evolution in pancreatic cancer mouse models","volume":"10","author":"Niknafs","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218276_bib33","doi-asserted-by":"crossref","first-page":"C540","DOI":"10.1152\/ajpcell.00331.2022","article-title":"Barriers and opportunities for gemcitabine in pancreatic cancer therapy","volume":"324","author":"Beutel","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.canlet.2026.218276_bib34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bjc.6600171","article-title":"Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma","volume":"86","author":"Gerhard","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218276_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102340","article-title":"Targeted mitochondrial therapy for pancreatic cancer","volume":"54","author":"Zhao","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218276_bib36","first-page":"1253","article-title":"Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis","volume":"25","author":"Chen","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2026.218276_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI195970","article-title":"ZEB1 promotes chemoimmunotherapy resistance in pancreatic cancer models by downregulating chromatin acetylation of CXCL16","volume":"135","author":"Zhang","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218276_bib38","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/j.gastro.2019.10.038","article-title":"ZIP4 increases expression of transcription factor ZEB1 to promote integrin alpha3beta1 signaling and inhibit expression of the gemcitabine transporter ENT1 in pancreatic cancer cells","volume":"158","author":"Liu","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218276_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177533","article-title":"Polybromo 1\/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer","volume":"135","author":"Kawai","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218276_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41388-024-03215-w","article-title":"Targeting DDX3X eliminates leukemia stem cells in chronic myeloid leukemia by blocking NT5DC2 mRNA translation","volume":"44","author":"Duan","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218276_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112043","article-title":"Elevated PAF1-RAD52 axis confers chemoresistance to human cancers","volume":"42","author":"Rauth","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218276_bib42","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-09-3690","article-title":"5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity","volume":"70","author":"Vincent","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218276_bib43","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106065","article-title":"5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING","volume":"40","author":"Tian","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2026.218276_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6680883","article-title":"MXRA5 is a novel immune-related biomarker that predicts poor prognosis in glioma","volume":"2021","author":"Sun","year":"2021","journal-title":"Dis. Markers"},{"key":"10.1016\/j.canlet.2026.218276_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41419-023-05684-5","article-title":"Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer","volume":"14","author":"Peng","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218276_bib46","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.1038\/s41598-017-08851-9","article-title":"Prognostic significance of EDIL3 expression and correlation with mesenchymal phenotype and microvessel density in lung adenocarcinoma","volume":"7","author":"Jeong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218276_bib47","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.18632\/oncotarget.6772","article-title":"Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218276_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13058-018-1030-y","article-title":"Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance","volume":"20","author":"Zhang","year":"2018","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2026.218276_bib49","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1111\/cas.13384","article-title":"Diagnostic and prognostic role of urinary collagens in primary human bladder cancer","volume":"108","author":"Miyake","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218276_bib50","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1038\/s41598-020-64356-y","article-title":"Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics","volume":"10","author":"Yu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218276_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic cancer: a review of current treatment and novel therapies","volume":"36","author":"Kolbeinsson","year":"2023","journal-title":"J. Invest. Surg."},{"key":"10.1016\/j.canlet.2026.218276_bib52","first-page":"387","article-title":"Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways","volume":"6","author":"Zhao","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218276_bib53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12943-015-0461-7","article-title":"DDX3, a potential target for cancer treatment","volume":"14","author":"Bol","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218276_bib54","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2016.69.0032","article-title":"Cell-cycle therapeutics come of age","volume":"35","author":"Ingham","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218276_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520930113","article-title":"Expression patterns and prognostic values of the cyclin-dependent kinase 1 and cyclin A2 gene cluster in pancreatic adenocarcinoma","volume":"48","author":"Jiang","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.canlet.2026.218276_bib56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218276_bib57","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16805","article-title":"XYA-2: a marine-derived compound targeting apoptosis and multiple signaling pathways in pancreatic cancer","volume":"12","author":"Guan","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.canlet.2026.218276_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149451","article-title":"DT-13 inhibits the proliferation of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling","volume":"695","author":"Xie","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2026.218276_bib59","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","article-title":"Effective drug combinations in breast, Colon and pancreatic cancer cells","volume":"603","author":"Jaaks","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218276_bib60","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/path.925","article-title":"Bcl-2 expression in pancreas development and pancreatic cancer progression","volume":"194","author":"Campani","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218276_bib61","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/gut.43.3.414","article-title":"Bax, but not bcl-2, influences the prognosis of human pancreatic cancer","volume":"43","author":"Friess","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218276_bib62","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-023-01815-w","article-title":"BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors","volume":"22","author":"Bertran-Alamillo","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218276_bib63","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41467-022-28741-7","article-title":"Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer","volume":"13","author":"Lopez","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218276_bib64","article-title":"DDX3 regulates cancer immune surveillance via 3' UTR-Mediated cell-surface expression of PD-L1","volume":"43","author":"Chen","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218276_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2646148","article-title":"Epithelial-Mesenchymal transition in pancreatic cancer: a review","volume":"2017","author":"Wang","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.canlet.2026.218276_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207624","article-title":"Role of cadherins in Cancer-A review","volume":"21","author":"Kaszak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218276_bib67","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/modpathol.2011.74","article-title":"Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas","volume":"24","author":"Hong","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2026.218276_bib68","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/bjc.2011.31","article-title":"Activated KrasG(1)(2)D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin","volume":"104","author":"Rachagani","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218276_bib69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.seminoncol.2021.02.003","article-title":"KRAS mutation in pancreatic cancer","volume":"48","author":"Luo","year":"2021","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2026.218276_bib70","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1200\/JCO.23.00434","article-title":"Adagrasib in advanced solid tumors harboring a KRAS(G12C) mutation","volume":"41","author":"Bekaii-Saab","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218276_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215922","article-title":"Small molecule inhibitor against onco-mucins disrupts Src\/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma","volume":"551","author":"Zhang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218276_bib72","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1053\/j.gastro.2021.08.023","article-title":"Pancreatic Tumor microenvironment factor promotes cancer stemness via SPP1-CD44 axis","volume":"161","author":"Nallasamy","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218276_bib73","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/j.gastro.2023.12.018","article-title":"Cancer-associated fibroblast induces acinar-to-ductal cell transdifferentiation and pancreatic cancer initiation via LAMA5\/ITGA4 axis","volume":"166","author":"Parte","year":"2024","journal-title":"Gastroenterology"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600039X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600039X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:09:29Z","timestamp":1777550969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352600039X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":73,"alternative-id":["S030438352600039X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218276","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the DDX3\/PAF1 axis enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218276"}}